1. Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial. (20th August 2021) Authors: Cowan, R.A.; Scarisbrick, J.J.; Zinzani, P.L.; Nicolay, J.P.; Sokol, L.; Pinter‐Brown, L.; Quaglino, P.; Iversen, L.; Dummer, R.; Musiek, A.; Foss, F.; Ito, T.; Rosen, J‐P.; Medley, M.C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 11(2021) Page Start: 2225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. (23rd June 2015) Authors: Klemke, C.D.; Booken, N.; Weiss, C.; Nicolay, J.P.; Goerdt, S.; Felcht, M.; Géraud, C.; Kempf, W.; Assaf, C.; Ortonne, N.; Battistella, M.; Bagot, M.; Knobler, R.; Quaglino, P.; Arheiliger, B.; Santucci, M.; Jansen, P.; Vermeer, M.H.; Willemze, R. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. (1st July 2015) Authors: Klemke, C.D.; Booken, N.; Weiss, C.; Nicolay, J.P.; Goerdt, S.; Felcht, M.; Géraud, C.; Kempf, W.; Assaf, C.; Ortonne, N.; Battistella, M.; Bagot, M.; Knobler, R.; Quaglino, P.; Arheiliger, B.; Santucci, M.; Jansen, P.; Vermeer, M.H.; Willemze, R. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network. (1st July 2021) Authors: Wehkamp, U.; Mitteldorf, C.; Stendel, S.; Stranzenbach, R.; Nicolay, J.P.; Wobser, M.; Weichenthal, M.; Schneiderbauer, R.; Klemke, C.‐D.; Hillen, U.; Kempf, W.; Assaf, C. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network. (7th May 2021) Authors: Wehkamp, U.; Mitteldorf, C.; Stendel, S.; Stranzenbach, R.; Nicolay, J.P.; Wobser, M.; Weichenthal, M.; Schneiderbauer, R.; Klemke, C.‐D.; Hillen, U.; Kempf, W.; Assaf, C. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The importance of assessing blood tumour burden in cutaneous T‐cell lymphoma. (1st February 2021) Authors: Vermeer, M.H.; Nicolay, J.P.; Scarisbrick, J.J.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The importance of assessing blood tumour burden in cutaneous T‐cell lymphoma. (1st July 2021) Authors: Vermeer, M.H.; Nicolay, J.P.; Scarisbrick, J.J.; Zinzani, P.L. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗